Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/JU.0000000000002193 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy. Reply.
J Urol
December 2021
Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy. Letter.
J Urol
December 2021
Division of Urology, Department of Surgery, University of Missouri, Columbia, Missouri.
SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy.
J Urol
August 2021
Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Purpose: Pain is the leading cause of unplanned emergency department visits and readmissions after ureteroscopy, making postoperative analgesic stewardship a priority given the current opioid epidemic. We conducted a double-blinded, randomized controlled trial, with noninferiority design, comparing nonsteroidal anti-inflammatory drugs to opiates for postoperative pain control in patients undergoing ureteroscopy for urolithiasis.
Materials And Methods: Patients were randomized and blinded to either oxycodone (5 mg) or ketorolac (10 mg), taken as needed, with 3 nonblinded oxycodone rescue pills for breakthrough pain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!